-
Loading metrics
Open Access
Peer-reviewed
Research Article
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits
-
Jin Zhou ,
Contributed equally to this work with: Jin Zhou, Jie Li
Roles Data curation, Formal analysis, Investigation, Writing – original draft, Writing – review & editing
¶‡ These authors are first authors on this work.
Affiliation Department of Neurology, State University of New York Downstate Medical Center, Brooklyn, New York, United States of America
⨯ -
Jie Li ,
Contributed equally to this work with: Jin Zhou, Jie Li
Roles Data curation, Formal analysis, Investigation, Methodology
¶‡ These authors are first authors on this work.
Affiliation Department of Neurology, State University of New York Downstate Medical Center, Brooklyn, New York, United States of America
⨯ -
Daniel M. Rosenbaum,
Roles Conceptualization, Funding acquisition, Supervision
Affiliations Department of Neurology, State University of New York Downstate Medical Center, Brooklyn, New York, United States of America, Robert F. Furchgott Foundation, State University of New York Downstate Medical Center, Brooklyn, New York, United States of America, Department of Physiology and Pharmacology, State University of New York Downstate Medical Center, Brooklyn, New York, United States of America
⨯ -
Jian Zhuang,
Roles Formal analysis, Methodology, Software
Affiliation Department of Neurology, State University of New York Downstate Medical Center, Brooklyn, New York, United States of America
⨯ -
Carrie Poon,
Roles Formal analysis, Methodology, Visualization
Affiliation Department of Neurology, State University of New York Downstate Medical Center, Brooklyn, New York, United States of America
⨯ -
Pu Qin,
Roles Data curation, Methodology, Validation
Affiliation Cardiac Biology, Heart Failure Discovery Performance Unit, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania, United States of America
⨯ -
Katrina Rivera,
Roles Data curation, Methodology, Validation
Affiliation Cardiac Biology, Heart Failure Discovery Performance Unit, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania, United States of America
⨯ -
John Lepore,
Roles Data curation, Methodology, Validation
Affiliation Cardiac Biology, Heart Failure Discovery Performance Unit, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania, United States of America
⨯ -
Robert N. Willette,
Roles Data curation, Methodology, Validation
Affiliation Cardiac Biology, Heart Failure Discovery Performance Unit, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania, United States of America
⨯ -
Erding Hu,
Roles Conceptualization, Funding acquisition, Methodology, Supervision
Affiliation Cardiac Biology, Heart Failure Discovery Performance Unit, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania, United States of America
⨯ -
Frank C. Barone
Roles Conceptualization, Funding acquisition, Investigation, Supervision, Writing – review & editing
* E-mail: frank.barone@downstate.edu
Affiliations Department of Neurology, State University of New York Downstate Medical Center, Brooklyn, New York, United States of America, Robert F. Furchgott Foundation, State University of New York Downstate Medical Center, Brooklyn, New York, United States of America, Department of Physiology and Pharmacology, State University of New York Downstate Medical Center, Brooklyn, New York, United States of America
⨯
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits
- Jin Zhou,
- Jie Li,
- Daniel M. Rosenbaum,
- Jian Zhuang,
- Carrie Poon,
- Pu Qin,
- Katrina Rivera,
- John Lepore,
- Robert N. Willette,
- Erding Hu
- Published: September 7, 2017
- https://doi.org/10.1371/journal.pone.0184049